iShares Biotechnology ETF (IBB)
NASDAQ: IBB
· Real-Time Price · USD
140.96
1.89 (1.36%)
At close: Sep 26, 2025, 3:59 PM
140.60
-0.26%
After-hours: Sep 26, 2025, 06:44 PM EDT
1.36% (1D)
| Bid | 139.07 |
| Market Cap | 9.82B |
| AUM | 5.77B |
| NAV | 141.67 |
| EPS (ttm) | 6.80 |
| PE Ratio (ttm) | 20.74 |
| Shares Out | 69.7M |
| Inception Date | Feb 5, 2001 |
| Ask | 143.45 |
| Volume | 1,932,870 |
| Open | 139.87 |
| Previous Close | 139.07 |
| Day's Range | 139.20 - 141.02 |
| 52-Week Range | 107.43 - 150.04 |
| Holdings | 250 |
| Expense Ratio | 0.44% |
About IBB
The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
Asset Class Equity
Ticker Symbol IBB
Inception Date Feb 5, 2001
Provider Blackrock
Website Fund Home Page
Exchange NASDAQ
Top 10 Holdings 48.92% of assets
| Name | Symbol | Weight |
|---|---|---|
| Gilead Sciences, Inc... | GILD | 7.85% |
| Amgen Inc. | AMGN | 7.73% |
| Vertex Pharmaceutica... | VRTX | 7.53% |
| Regeneron Pharmaceut... | REGN | 5.83% |
| Alnylam Pharmaceutic... | ALNY | 5.74% |
| Argenx Se | ARGX | 3.18% |
| Iqvia Holdings Inc. | IQV | 3.16% |
| Insmed Incorporated | INSM | 3.02% |
| Mettler-toledo Inter... | MTD | 2.58% |
| Natera, Inc. | NTRA | 2.30% |
Dividends Dividend Yield 0.19%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Sep 16, 2025 | $0.0828 | Sep 19, 2025 |
| Mar 18, 2025 | $0.1212 | Mar 21, 2025 |
| Dec 17, 2024 | $0.0624 | Dec 20, 2024 |
| Sep 25, 2024 | $0.2005 | Sep 30, 2024 |
| Mar 21, 2024 | $0.1260 | Mar 27, 2024 |
3 weeks ago · seekingalpha.com
BBH Vs. IBB: How To Prepare For The Next Biotech Growth Cycle With BBHBiotech is entering a new growth cycle driven by AI and CRISPR innovation, but current ETF valuations are high and volatility is elevated. BBH offers a concentrated portfolio of leading innovators wit...
2 months ago · seekingalpha.com
5 Stocks I'm Buying As The 'Big Beautiful Bill' Pushes The Market To New HighsThe Big Beautiful Bill boosts defense, industrials, and manufacturing, but healthcare and some REITs face headwinds from Medicaid cuts and policy shifts. AI optimism and the new legislation are fuelin...